Younger donor's age and upfront tandem are two independent prognostic factors for survival in multiple myeloma patients treated by tandem autologous-allogeneic stem cell transplantation: a retrospective study from the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).

@article{Fabre2012YoungerDA,
  title={Younger donor's age and upfront tandem are two independent prognostic factors for survival in multiple myeloma patients treated by tandem autologous-allogeneic stem cell transplantation: a retrospective study from the Soci{\'e}t{\'e} Française de Greffe de Moelle et de Th{\'e}rapie Cellulaire (SFGM-TC).},
  author={Claire Fabre and Serge Koscielny and Mohamad Mohty and Nathalie Fegueux and Didier Blaise and Natacha Maillard and Reza Tabrizi and Mauricette Michallet and Gerard J Soci{\'e} and Ibrahim Yakoub-Agha and Fr{\'e}d{\'e}ric Garban and Madalina Uzunov and Sylvie François and Nathalie Contentin and Simona Lapusan and J. Bourhis},
  journal={Haematologica},
  year={2012},
  volume={97 4},
  pages={482-90}
}
BACKGROUND How tandem autologous-allogeneic stem cell transplantation should be integrated in the treatment of multiple myeloma remains controversial. We examined the long-term outcome of patients with multiple myeloma managed with tandem autologous-allogeneic stem cell transplantation and present a prognostic factor analysis based on the experience of the Société Française de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC). DESIGN AND METHODS This French, retrospective, registry-based… CONTINUE READING

References

Publications referenced by this paper.
Showing 1-10 of 31 references

Graft-versus-myeloma effect: proof of principle.

Blood • 1996
View 1 Excerpt
Highly Influenced

Cox regression analysis of multivariate failure time data: the marginal approach.

Statistics in medicine • 1994
View 2 Excerpts
Highly Influenced

Tandem autologous/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 2011
View 2 Excerpts

Allogeneic stem cell transplant versus tandem high-dose melphalan for front-line treatment of deletion 13q14 myeloma: An interim analysis of the German DSMM V trial

S LPKnop, H Hebart, al
2009
View 1 Excerpt

Similar Papers

Loading similar papers…